Biogen Idec to Present at the Credit Suisse 2008 Healthcare Conference

November 7, 2008 • Investor Relations

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at the Credit Suisse 2008 Healthcare Conference will be webcast live via the internet, on Wednesday, November 12th, 2008 at 6:00 p.m. EST. To access the live webcast, please visit Biogen Idec’s Investor Relations section (investor.biogenidec.com). An archived version of the webcast will be available for 14 days following the presentation.

About Biogen Idec

Biogen Idec creates new standards of care in oncology, neurology and immunology. As a global leader in the development, manufacturing, and commercialization of novel therapies, Biogen Idec transforms scientific discoveries into advances in human healthcare. For product labeling, press releases and additional information about the company, please visit http://www.biogenidec.com.

Contact:

 

Biogen Idec
Heidi Brewster, 617-679-2757
Investor Relations

thumb
October 6, 2021
Biogen to Report Third Quarter 2021 Financial Results October 20, 2021

Cambridge, Mass.— Biogen Inc. (Nasdaq:BIIB) today announced it will report third quarter 2021 financial results Wednesday, October 20, 2021, before the financial markets open.  Following the release of the financials, the Company will host a live webcast with Biogen management at 8:00 a.m. ET.

Read More
thumb
October 4, 2021
Sage Therapeutics and Biogen Announce Consistent Clinically Meaningful Data for Zuranolone Across the LANDSCAPE and NEST Clinical Development Programs Presented at the European College of Neuropsychopharmacology (ECNP) Congress

Improvement achieved in measurements of overall quality of life, functioning and general well-being achieved at Day 15 and sustained at Day 42 Consistent and differentiated safety and tolerability profile seen across clinical program Sage to host conference call on October 4, 2021 at 8:00am ET

Read More